Collplant生物技術 CLGN 深 滬
等待開盤 04-07 09:30:00 美东时间
0.441
-0.088
-16.64%
華盛通- 最 高0.52
- 今 開0.49
- 成交量 10.30万股
- 最 低 0.4333
- 昨 收 0.529
- 總市值 635.71万
- 52周最高 4.98
- 市盈率 靜 --
- 換手率 0.71%
- 52周最低 0.4333
- 委 比 -90.48%
- 總股本 1441.51万
- 歷史最高 24.26
- 量 比 2.16
- 振 幅 16.39%
- 歷史最低 0.4333
- 每 手 1
- 風險率 0.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CollPlant Biotechnologies Q4 Adj. EPS $(0.25) Misses $(0.19) Estimate, Sales $60.000K Miss $1.524M Estimate.
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by 31.58 percent. This is a 16.67 percent increase over losses of $(0.30) per
03-26 20:34
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...
03-26 20:30
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
CollPlant Biotechnologies Receives Nasdaq Noncompliance Notice, Gets Time Through Sept. 21 To Regain Compliance
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) platform, today
03-25 04:02
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
REHOVOT, Israel, March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based ...
03-25 04:01
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers ENvue Medical (NASDAQ:FEED) shares increased by 59.4% to $2.28 during T...
03-25 01:05
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
BioFlex Enables Rapid Formulation of Tunable rhCollagen Bioinks with Enhanced Tissue-Mimetic Performance BioFlex Expands CollPlant's Animal-Free Bioink Platform for Biopharma companies and A...
02-23 20:00
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapies REHOVOT, Israel,...
02-17 20:00
This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-06 22:35
D. Boral Capital Downgrades CollPlant Biotechnologies to Hold
D. Boral Capital analyst Jason Kolbert downgrades CollPlant Biotechnologies (NASDAQ:CLGN) from Buy to Hold.
02-06 20:57
